REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc., trading under the ticker PAIC, filed an 8-A12B registration statement on July 13, 2026, registering a class of its securities under Section 12(b) of the Securities Exchange Act of 1934 in connection with a listing on a national securities exchange. The company operates in the life sciences and biotechnology sector, and the filing marks a significant step in its public market status. Sponsor details have not been confirmed through available public disclosures at this time. The 8-A12B is a standard milestone in the SPAC or post-merger registration process for companies entering exchange-listed trading. Sign up at SpacDesk for full filing history, sponsor data, and real-time SPAC pipeline coverage across the biotech space.